Summary
Client: imshealth | brogan
Project ID: P2016-009 / 2017 0970 081 000
Research Question/Objectives: Hypoparathyroidism is a rare disease as noted by NORD and typically is caused by damage to the parathyroid during head and neck surgery. Treatment is chronic and consists of vitamin D and calcium supplements. In contrast to hyperparathyroidism, hypoparathyroidism is not well studied, and only five prevalence studies have been published outside of Canada. This study aims to understand the epidemiology and burden of hypoparathyroidism in Ontario. Specifically, the research questions of interest are:
- What is the prevalence, incidence, and burden of illness of hypoparathyroidism in Ontario?
- What treatments are received by hypoparathyroidism patients in Ontario?
- What are the costs and resource utilization of Ontarians with hypoparathyroidism?
Status: Completed
Results:
- Data set creation plan
- Final deliverables — phase 1, phase 2
Private Sector Project
2026
Real-world study on the effectiveness of nirmatrelvir-ritonavir in reducing severe outcomes from COVID-19
Project ID: P2023-184/ 2026 0980 010
Project Year: 2026
Status: In progress
Private Sector Project
2026
CARE: A Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
Project ID: P2024-226/ 2026 0980 009 000
Project Year: 2026
Status: In progress